Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
PPD Catalyst Calendar
Proactively evaluate PPD Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of PPD Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 27 Aug 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 26 Aug 2019 | Phase III Trial Results | Alnylam Pharmaceuticals Inc; PPD Inc; The Medicines Co | ALNY | inclisiran | Cardiovascular; Metabolic Disorders | Atherosclerosis; Cardiovascular Disease; Cardiovascular Risk Factors; Coronary Artery Disease (CAD) (Ischemic Heart Disease); Familial Hypercholesterolemia (Type II Hyperlipoproteinemia); Hypercholesterolemia; Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD); Type 2 Diabetes | Company Press Release |
| 19 Aug 2019 | Phase I Trial Completion | Johnson & Johnson; PPD Inc; ViiV Healthcare UK Ltd | JNJ | (dolutegravir sodium + rilpivirine hydrochloride) | Infectious Disease | Human Immunodeficiency Virus (HIV) Infections (AIDS) | Clinical Trial Registry |
| 19 Aug 2019 | Phase I Trial Completion | GSK plc; PPD Inc | GSK | GSK-3439171A | Genetic Disorders | Duchenne Muscular Dystrophy | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer